Preferential externalization of newly synthesized phosphatidylserine in apoptotic U937 cells is dependent on caspase-mediated pathways

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1487, Issue 2-3, 2000, Pages 296-308

  Yu, Anan ^a   Byers, David M ^a   Ridgway, Neale D ^a   McMaster, Christopher R ^a   Cook, Harold W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Camptothecin; Caspase; Phosphatidylserine; Phospholipid; U937 cell

Indexed keywords

CAMPTOTHECIN; CASPASE; CASPASE INHIBITOR; DNA TOPOISOMERASE INHIBITOR; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; SPHINGOMYELIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL FREE SYSTEM; CELL STRAIN U937; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIPID TRANSPORT; MEMBRANE VESICLE; PHASE CONTRAST MICROSCOPY; PHOSPHOLIPID METABOLISM; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

APOPTOSIS; CAMPTOTHECIN; CASPASES; CELL MEMBRANE; CELL-FREE SYSTEM; ENZYME INHIBITORS; EXOCYTOSIS; HUMAN; PHOSPHATIDYLSERINES; SUPPORT, NON-U.S. GOV'T; TRITIUM; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0034721547     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00100-1     Document Type: Article

References (51)

1. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
2. Jacobson M.D., Weil M., Raff M.C. Programmed cell death in animal development. Cell. 88:1997;347-354.
3. Winoto A. Cell death in the regulation of immune responses. Curr. Opin. Immunol. 9:1997;365-370.
4. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
5. Fadeel B., Orrenius S., Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony. Biochem. Biophys. Res. Commun. 266:1999;699-717.
6. Konopleva M., Zhao S., Xie Z., Segall H., Younes A., Claxton D.F., Estrov Z., Kornblau S.M., Andreeff M. Apoptosis. Molecules and mechanisms. Adv. Exp. Med. Biol. 457:1999;217-236.
7. McConkey D.J., Orrenius S. Signal transduction pathways in apoptosis. Stem Cells. 14:1996;619-631.
8. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M.E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254:1998;439-459.
9. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
10. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
11. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA. 96:1999;10964-10967.
12. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., vanSchie R.C., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1995;1545-1556.
13. Krahling S., Callahan M.K., Williamson P., Schlegel R.A. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 6:1999;183-189.
14. Fadok V.A., Bratton D.L., Frasch S.C., Warner M.L., Henson P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5:1998;551-562.
15. Bratton D.L., Fadok V.A., Richter D.A., Kailey J.M., Guthrie L.A., Henson P.M. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272:1997;26159-26165.
16. Hampton M.B., Vanags D.M., Porn-Ares M.I., Orrenius S. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett. 399:1996;277-282.
17. 2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells. Biochemistry. 38:1999;10092-10098.
18. Zhao J., Zhou Q., Wiedmer T., Sims P.J. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J. Biol. Chem. 273:1998;6603-6606.
19. Vanags D.M., Porn-Ares M.I., Coppola S., Burgess D.H., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.
20. Bevers E.M., Comfurius P., Dekkers D.W., Zwaal R.F. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta. 1439:1999;317-330.
21. Bevers E.M., Comfurius P., Dekkers D.W., Harmsma M., Zwaal R.F. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance. Biol. Chem. 379:1998;973-986.
22. Martin S.J., Finucane D.M., Amarante-Mendes G.P., O'Brien G.A., Green D.R. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:1996;28753-28756.
23. Naito M., Nagashima K., Mashima T., Tsuruo T. Phosphatidylserine externalization is a downstream event of interleukin-1β-converting enzyme family protease activation during apoptosis. Blood. 89:1997;2060-2066.
24. Drenou B., Blancheteau V., Burgess D.H., Fauchet R., Charron D.J., Mooney N.A. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J. Immunol. 163:1999;4115-4124.
25. Deas O., Dumont C., MacFarlane M., Rouleau M., Hebib C., Harper F., Hirsch F., Charpentier B., Cohen G.M., Senik A. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161:1998;3375-3383.
26. Brown S.B., Clarke M.C., Magowan L., Sanderson H., Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J. Biol. Chem. 275:2000;5987-5996.
27. Kuge O., Nishijima M., Akamatsu Y. A Chinese hamster cDNA encoding a protein essential for phosphatidylserine synthase I activity. J. Biol. Chem. 266:1991;24184-24189.
28. Kuge O., Saito K., Nishijima M. Cloning of a Chinese hamster ovary (CHO) cDNA encoding phosphatidylserine synthase (PSS) II, overexpression of which suppresses the phosphatidylserine biosynthetic defect of a PSS I-lacking mutant of CHO-K1 cells. J. Biol. Chem. 272:1997;19133-19139.
29. Saito K., Nishijima M., Kuge O. Genetic evidence that phosphatidylserine synthase II catalyzes the conversion of phosphatidylethanolamine to phosphatidylserine in Chinese hamster ovary cells. J. Biol. Chem. 273:1998;17199-17205.
30. Kuge O., Nishijima M. Phosphatidylserine synthase I and II of mammalian cells. Biochim. Biophys. Acta. 1348:1997;151-156.
31. Shiao Y.J., Lupo G., Vance J.E. Evidence that phosphatidylserine is imported into mitochondria via a mitochondria-associated membrane and that the majority of mitochondrial phosphatidylethanolamine is derived from decarboxylation of phosphatidylserine. J. Biol. Chem. 270:1995;11190-11198.
32. Vance J.E., Shiao Y.J. Intracellular trafficking of phospholipids: import of phosphatidylserine into mitochondria. Anticancer Res. 16:1996;1333-1339.
33. Kuge O., Hasegawa K., Saito K., Nishijima M. Control of phosphatidylserine biosynthesis through phosphatidylserine-mediated inhibition of phosphatidylserine synthase I in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 95:1998;4199-4203.
34. Kuge O., Saito K., Nishijima M. Control of phosphatidylserine synthase II activity in Chinese hamster ovary cells. J. Biol. Chem. 274:1999;23844-23849.
35. Aussel C., Pelassy C., Breittmayer J.P. CD95 (Fas/APO-1) induces an increased phosphatidylserine synthesis that precedes its externalization during programmed cell death. FEBS Lett. 431:1998;195-199.
36. Anthony M.L., Zhao M., Brindle K.M. Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells. J. Biol. Chem. 274:1999;19686-19692.
37. Galavazi G., Schenk H., Bootsma D. Synchronization of mammalian cells in vitro by inhibition of the DNA synthesis. I. Optimal conditions. Exp. Cell Res. 41:1966;428-437.
38. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
39. Thomas S.E., Byers D.M., Palmer F.B.S.C., Spence M.W., Cook H.W. Incorporation of polyunsaturated fatty acids into plasmalogens, compared to other phospholipids of cultured glioma cells, is more dependent on chain length than on selectivity between (n-3) and (n-6) families. Biochim. Biophys. Acta Lipids Lipid Metab. 1044:1990;349-356.
40. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
41. Rothenberg M.L. Topoisomerase I inhibitors: review and update. Ann. Oncol. 8:1997;837-855.
42. Johnson N., Ng T.T., Parkin J.M. Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis. Leuk. Res. 21:1997;961-972.
43. Gorczyca W., Gong J., Ardelt B., Traganos F., Darzynkiewicz Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53:1993;3186-3192.
44. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
45. Villa P., Kaufmann S.H., Earnshaw W.C. Caspases and caspase inhibitors. Trends Biochem. Sci. 22:1997;388-393.
46. Garcia-Calvo M., Peterson E.P., Leiting B., Ruel R., Nicholson D.W., Thornberry N.A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273:1998;32608-32613.
47. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
48. Kull F.C. Jr., Besterman J.M. Drug-induced alterations of tumor necrosis factor-mediated cytotoxicity: discrimination of early versus late stage action. J. Cell Biochem. 42:1990;1-12.
49. Wright S.C., Zheng H., Zhong J. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J. 10:1996;325-332.
50. Colbeau A., Nachbaur J., Vignais P.M. Enzymic characterization and lipid composition of rat liver subcellular membranes. Biochim. Biophys. Acta. 249:1971;462-492.
51. Khwaja A., Tatton L. Resistance to the cytotoxic effects of tumor necrosis factor α can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274:1999;36817-36823.